HIMSNYSEServices-Offices & Clinics of Doctors of MedicineUS GAAP · USD

Hims & Hers Health, Inc.

Hims & Hers Health, Inc. runs a consumer-first digital health platform that connects patients to licensed clinicians, online prescriptions, and pharmacy fulfillment. Founded in 2017, it focuses on routine and recurring care areas such as sexual health, hair loss, hormone health, weight loss, dermatology, mental health, and lab testing, delivered through its websites and mobile apps.

Kysy yhtiöstä
Liikevaihto2 348milj. USD
+59,0 %v/v
Liikevoitto (EBIT)106milj. USD
+70,6 %v/v
EBIT-marginaali4,5%
+0,3 %-yks.v/v
Nettotulos128milj. USD
+1,8 %v/v
Vapaa kassavirta300milj. USD
+19,5 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−50005001 0001 5002 0002 500milj. USD2020: 149 milj. USD2020: EBIT −15 milj. USD20202021: 272 milj. USD2021: EBIT −115 milj. USD20212022: 527 milj. USD2022: EBIT −69 milj. USD20222023: 872 milj. USD2023: EBIT −29 milj. USD20232024: 1 477 milj. USD2024: EBIT 62 milj. USD20242025: 2 348 milj. USD2025: EBIT 106 milj. USD20252 348106
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Hims & Hers Health, Inc.

Liiketoiminta

Osuus liikevaihdosta
Prescription telehealth treatments70 %

Condition-specific online consultations, clinician visits, and prescription therapies fulfilled through the platform.

Non-prescription wellness products10 %

Over-the-counter and wellness products sold directly to consumers through digital and retail channels.

Laboratory testing and diagnostics8 %

At-home or facilitated lab testing used to support diagnosis, treatment selection, and follow-up care.

Pharmacy and fulfillment services7 %

Cloud-enabled dispensing, packaging, and shipping services that support recurring treatment delivery.

Platform access and care services5 %

Digital care infrastructure, follow-up support, and app-based health content that improve retention and engagement.

Asiakkaat

The company sells directly to consumers who want convenient, private, and lower-friction access to care for sensitive or recurring conditions. Its core users are people seeking treatment for the first time or looking for ongoing subscription-based care in areas where stigma, access barriers, or convenience matter. It also reaches shoppers for non-prescription wellness products, including through retail locations in the United States.

Direct-to-consumer prescription patients

Buy clinician-guided prescription treatments for sexual health, hair loss, weight loss, dermatology, hormone health, and mental health because the platform is private and convenient.

Subscription-based recurring care users

Purchase ongoing treatment plans and refills through the app because the model supports continuity, follow-up, and convenience.

Non-prescription wellness shoppers

Buy over-the-counter health and wellness products for self-directed care and everyday maintenance.

Lab testing and diagnostics users

Order testing to support diagnosis, treatment selection, and monitoring for conditions managed on the platform.

Retail channel consumers

Purchase non-prescription products in U.S. retail locations, extending the brand beyond the app ecosystem.

Strategia

The company is focused on expanding customer acquisition, increasing cross-sell within its existing base, and broadening the number of conditions it can treat. It is also investing in marketing infrastructure, technology, and clinical capabilities to make the platform more personalized and easier to use, while recent acquisitions point to a longer-term push into adjacent digital health capabilities and geographies.

Customer acquisition at scaleLyhyt aikaväli

Growth depends on continuously bringing new users onto the platform at acceptable marketing returns.

Expand within the existing customer baseKeskipitkä aikaväli

Cross-sell and subscription retention improve lifetime value and reduce reliance on new-user growth.

Broaden clinical and product capabilitiesKeskipitkä aikaväli

More conditions and services increase platform relevance and make the brand harder to replace.

Selective acquisitions and international expansionPitkä aikaväli

Acquired platforms and new geographies can add users, capabilities, and long-term revenue pools.

Maantiede

Q1/2026

Hims & Hers serves customers in the United States, Canada, the United Kingdom, and parts of the European Union, including Germany, Ireland, France, and Spain. The business is still centered on the U.S., but its recent acquisitions and international platform expansion suggest a broader multi-country footprint over time. Geography matters because healthcare regulation, pharmacy operations, and telehealth rules differ by market and affect how quickly the company can scale.

USA87 %
Other countries (US filing)13 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

The business depends heavily on digital marketing efficiency, platform trust, and the ability to retain customers in a highly regulated healthcare environment. Cybersecurity, privacy, pharmacy operations, compounding, and changing telehealth or drug regulations are especially important because the model handles sensitive patient data and prescription fulfillment online.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Cybersecurity and data privacy breaches1Marketing inefficiency and customer acquisition slowdown2Regulatory changes affecting telehealth, prescriptions, and compounding3Competition from digital health, pharmacies, and traditional providers4Execution risk from acquisitions and international expansion5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Cybersecurity and data privacy breachesVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The platform stores and transmits sensitive patient information and relies on third parties for key functions.

    KohdistuuCustomer and patient dataCloud systemsVendor infrastructure
  2. Marketing inefficiency and customer acquisition slowdownVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Revenue depends on continuously enrolling new customers at acceptable returns on marketing spend.

    Kohdistuu: Direct-to-consumer demand generation

  3. Regulatory changes affecting telehealth, prescriptions, and compoundingVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The company operates in a heavily regulated healthcare and pharmaceutical environment.

    KohdistuuFDA rulesState and federal telehealth lawsPharmacy operations
  4. Competition from digital health, pharmacies, and traditional providersVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    The company competes against both niche digital rivals and larger healthcare organizations.

    KohdistuuSexual healthWeight lossDermatologyMental healthLab testing
  5. Execution risk from acquisitions and international expansionVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    New platforms and geographies can increase operating complexity before benefits are realized.

    KohdistuuIntegrationComplianceOperating expense growth
Kysy Clarifolta: Hims & Hers Health, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition for subscription prescriptions and services

The company derives a substantial majority of revenue from subscription-based purchases, so timing and fulfillment patterns matter.

Vaikutus: Quarterly revenue comparability and deferred revenue balances

Inventory valuation

Pharmacy fulfillment and product sales require estimates for obsolescence and realizability.

Vaikutus: Gross margin and inventory write-down risk

Stock-based compensation

A growing consumer platform often uses equity awards to attract and retain talent.

Vaikutus: Operating expenses and diluted share count

Business combination fair values and contingent consideration

Recent acquisitions introduce earn-outs and purchase accounting judgments.

Vaikutus: Goodwill, intangible assets, and future expense volatility

Lease and cloud software commitments

The company has operating leases and non-cancelable purchase obligations tied to operations.

Vaikutus: Fixed obligations and cash flow visibility

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Talkspace, Inc.

Services-Health Services

Cosmos Health Inc.

COSM · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Universal Health Services, Inc

UHS · Services-General Medical & Surgical Hospitals, NEC

eHealth, Inc.

EHTH · Insurance Agents, Brokers & Service

DLH Holdings Corp.

DLHC · Services-Help Supply Services

Oscar Health, Inc.

OSCR · Hospital & Medical Service Plans

Päivitetty: 24.9.2026

Hims & Hers Health, Inc. (HIMS) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo